Back to Search
CHRISJON FABIAN, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1386042414Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
72093(CA)
Research & Publications (20)
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
PMID 17892469·Int J Clin Pract·2007
6-review
Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
PMID 17221152·Breast Cancer Res Treat·2007
3-trial
Mammographic density: use in risk assessment and as a biomarker in prevention trials.
PMID 16988158·J Nutr·2006
8-other
Breast-tissue sampling for risk assessment and prevention.
PMID 15947097·Endocr Relat Cancer·2005
6-review
Selective estrogen-receptor modulators for primary prevention of breast cancer.
PMID 15755972·J Clin Oncol·2005
6-review
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator.
PMID 15328178·Clin Cancer Res·2004
3-trial
Breast cancer chemoprevention: current challenges and a look toward the future.
PMID 12123535·Clin Breast Cancer·2002
6-review
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
PMID 12374678·Clin Cancer Res·2002
3-trial
Chemoprevention of breast cancer: implications for postmenopausal women.
PMID 11929326·Drugs Aging·2002
6-review
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
PMID 11795443·Ann N Y Acad Sci·2001
6-review
Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.
PMID 10922407·J Natl Cancer Inst·2000
8-other
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.
PMID 19655244·Breast Cancer Res Treat·2010
8-other
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
PMID 19349550·J Clin Oncol·2009
3-trial
Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
PMID 19597020·J Clin Oncol·2009
8-other
Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
PMID 19125322·Breast Cancer Res Treat·2009
2-rct
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
PMID 18853415·Cancer·2008
8-other
Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
PMID 19139004·Cancer Prev Res (Phila)·2008
7-preclinical
Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
PMID 18006909·Cancer Epidemiol Biomarkers Prev·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7015 N WEST AVE
FRESNO, CA 93711 - Phone
- (559) 440-1404
Quick Facts
- NPI
- 1386042414
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile